GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.371 $0.93 Thursday, 18th Apr 2024 SNGX stock ended at $0.435. This is 14.65% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 13.87% from a day low at $0.411 to a day high of $0.468.
90 days $0.371 $0.93
52 weeks $0.371 $4.20

Historical Soligenix, Inc prices

Date Open High Low Close Volume
2024-04-18 $0.461 $0.468 $0.411 $0.435 6 296 230
2024-04-17 $0.481 $0.542 $0.440 $0.510 4 040 496
2024-04-16 $0.546 $0.609 $0.460 $0.472 8 969 970
2024-04-15 $0.677 $0.93 $0.450 $0.470 133 635 475
2024-04-12 $0.410 $0.410 $0.371 $0.386 263 825
2024-04-11 $0.480 $0.482 $0.387 $0.389 1 519 987
2024-04-10 $0.465 $0.470 $0.452 $0.463 102 165
2024-04-09 $0.480 $0.486 $0.460 $0.465 640 982
2024-04-08 $0.476 $0.500 $0.460 $0.484 58 619
2024-04-05 $0.500 $0.500 $0.470 $0.472 74 089
2024-04-04 $0.510 $0.510 $0.450 $0.470 138 135
2024-04-03 $0.538 $0.559 $0.460 $0.485 267 984
2024-04-02 $0.567 $0.570 $0.530 $0.540 78 061
2024-04-01 $0.600 $0.600 $0.550 $0.560 194 603
2024-03-28 $0.593 $0.610 $0.592 $0.600 137 509
2024-03-27 $0.600 $0.612 $0.600 $0.607 162 797
2024-03-26 $0.620 $0.620 $0.570 $0.590 61 929
2024-03-25 $0.620 $0.640 $0.604 $0.620 40 649
2024-03-22 $0.620 $0.660 $0.620 $0.635 26 605
2024-03-21 $0.646 $0.650 $0.632 $0.640 12 169
2024-03-20 $0.640 $0.650 $0.612 $0.625 38 996
2024-03-19 $0.601 $0.650 $0.600 $0.621 51 885
2024-03-18 $0.628 $0.640 $0.600 $0.610 199 239
2024-03-15 $0.640 $0.691 $0.620 $0.620 82 509
2024-03-14 $0.700 $0.705 $0.630 $0.637 159 568
Click to get the best stock tips daily for free!

About Soligenix, Inc

Soligenix Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of treat cutaneous T-cell lymphoma; and SGX942, an ... SNGX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT